Amgen's Ian Noble - 'If it doesn't get measured, it doesn't get done'

Amgen's director of value, access and policy, Ian Noble, says a vision and agreed principles are essential to ensuring the pending HTA review avoids becoming just another negotiation and actually delivers for Australian patients. …